Human iPSC-derived Neuron Maturation IF Antibody Sampler Kit #68228
Product Information
Kit Usage Information
Protocols
- 2837: Western Blotting, Immunohistochemistry (Paraffin), Immunofluorescence
- 3450: Western Blotting, Immunofluorescence, Immunofluorescence
- 5568: Western Blotting, Immunoprecipitation (Agarose), Immunofluorescence, Immunofluorescence
- 7074: Western Blotting
- 23064: Western Blotting, Immunoprecipitation (Agarose), Immunofluorescence, Immunofluorescence, Flow, ChIP Magnetic, Chromatin IP-seq, CUT&RUN Assay
- 24307: Western Blotting, Immunohistochemistry (Paraffin), Immunofluorescence
- 56130: Western Blotting, Immunoprecipitation (Magnetic), Immunofluorescence, Immunofluorescence
- 62953: Western Blotting, Immunoprecipitation (Magnetic), Immunofluorescence, Immunofluorescence
- 73349: Western Blotting, Immunoprecipitation (Agarose), Immunohistochemistry (Paraffin), Immunofluorescence
- 99746: Western Blotting, Immunoprecipitation (Agarose), Immunohistochemistry (Leica® Bond™), Immunohistochemistry (Paraffin), Immunofluorescence, Immunofluorescence, Flow
Product Description
Background
Doublecortin is a microtubule-associated protein that facilitates neurite outgrowth and cell migration (8). The dual expression of doublecortin and neural cell adhesion molecule (NCAM, also known as CD56), combined with the lack of expression of mature neuronal markers, is evidence of an immature neuronal phenotype (9). NCAM mediates neuronal attachment, neurite extension, and cell-to-cell interactions through homo and heterophilic interactions. Polysialic acid (PSA) post-translational modification of NCAM disrupts cell-to-cell adhesion, promoting axonal growth, cell migration, and synaptic plasticity during neurogenesis (10-12).
Transcription factors also play a key role in immature neuron growth and differentiation. Research studies demonstrate that a set of transcription factors that includes Oct-4, Sox2, and Nanog forms a transcriptional network that maintains cells in a pluripotent state (13,14). Sox2 is highly expressed in neural stem/progenitor cells and is largely downregulated in post-mitotic neurons and glia (15). NeuroD1 is a member of the basic helix-loop-helix (BHLH) family of transcription factors. These proteins function by forming heterodimers with E-proteins and binding to the canonical E-box sequence CANNTG (7,8). NeuroD1 functions to promote cell survival and neuronal differentiation (16,17). Neuronal activity results in CaMKII-mediated phosphorylation of NeuroD1 at Ser336, which is necessary for the formation and growth of dendrites (18,19).
Several neuron-enriched markers can be used to identify mature neurons. Neuronal nuclei (NeuN), also known as Fox-3 or RBFOX3, is a nuclear protein expressed in most post-mitotic neurons of the central and peripheral nervous systems. NeuN is not detected in Purkinje cells, sympathetic ganglion cells, Cajal-Retzius cells, INL retinal cells, inferior olivary, or dentate nucleus neurons (20). Mature neurons function as cellular mediators of synaptic transmission. Postsynaptic Density protein 95 (PSD95) is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. These family members consist of an amino-terminal variable segment followed by three PDZ domains, an SH3 domain, and an inactive guanylate kinase (GK) domain. PSD95 is a scaffolding protein involved in the assembly and function of the mature postsynaptic density complex (21,22).
- Michalczyk, K. and Ziman, M. (2005) Histol Histopathol 20, 665-71.
- Gilyarov, A.V. (2008) Neurosci Behav Physiol 38, 165-9.
- Giliarov, A.V. (2007) Morfologiia 131, 85-90.
- Al-Chalabi, A. and Miller, C.C. (2003) Bioessays 25, 346-55.
- Cohlberg, J.A. et al. (1995) J Biol Chem 270, 9334-9.
- Jiang, Y.Q. and Oblinger, M.M. (1992) J Cell Sci 103 ( Pt 3), 643-51.
- Tischfield, M.A. et al. (2010) Cell 140, 74-87.
- Reiner, O. et al. (2004) Cell Cycle 3, 747-51.
- Coviello, S. et al. (2022) Front Neuroanat 16, 851432.
- Seidenfaden, R. et al. (2003) Mol Cell Biol 23, 5908-18.
- Bonfanti, L. and Seki, T. (2021) Cells 10, 2542. doi: 10.3390/cells10102542.
- Wędzony, K. et al. (2013) Pharmacol Rep 65, 1471-8.
- Pesce, M. and Schöler, H.R. (2001) Stem Cells 19, 271-8.
- Pan, G. and Thomson, J.A. (2007) Cell Res 17, 42-9.
- Zhang, S. and Cui, W. (2014) World J Stem Cells 6, 305-11.
- Gao, Z. et al. (2009) Nat Neurosci 12, 1090-2.
- Tutukova, S. et al. (2021) Front Mol Neurosci 14, 662774.
- Chae, J.H. et al. (2004) Mol Cells 18, 271-88.
- Gaudillière, B. et al. (2004) Neuron 41, 229-41.
- Mullen, R.J. et al. (1992) Development 116, 201-11.
- Cao, J. et al. (2005) J Cell Biol 168, 117-26.
- Chetkovich, D.M. et al. (2002) J Neurosci 22, 6415-25.
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.